Simulations Plus (SLP) Q1 2026 earnings review
Software Stumbles, Dragging Top Line into Negative Territory
Simulations Plus began FY26 with a 3% revenue decline, marking a sharp reversal from the double-digit growth seen earlier in FY25. The core software segment—historically the high-margin growth engine—collapsed 17% YoY, outweighing a 16% gains in Services. While management cited 'meeting guidance' and pointed to tough comps, the deterioration in software renewal rates (down to 88% from 95%) and compressed EBITDA margins (19% vs 24%) signal fundamental headwinds. The company reiterated FY26 guidance for 0-4% growth, implying a heavy reliance on a second-half recovery.
🐂 Bull Case
Services revenue accelerated to +16% YoY ($9.5M), driven by commercialization offerings. The backlog remains robust at $20.4M, providing visibility for continued service revenue stability.
Despite the software decline, total Gross Margin improved significantly to 59% from 54% a year ago, suggesting improved efficiency in the services delivery model or favorable mix shifts within the specific service lines.
🐻 Bear Case
Software revenue fell 17% YoY to $8.9M. This segment, which typically commands higher multiples, now constitutes less than half (48%) of total revenue, representing a negative mix shift from 57% a year ago.
The fee-based software renewal rate dropped to 88% from 95% in 25Q1. Management blames 'client consolidations,' but a 700bps drop suggests potential competitive losses or churn in the acquired Pro-ficiency assets.
⚖️ Verdict: 🔴
Bearish. The thesis of SLP as a high-margin software compounder is under threat. With software revenue shrinking double-digits and renewal rates falling, the reliance on lower-margin Services to float the boat is a structural concern.
Key Themes
Software Segment Reversal
The core thesis for SLP has been its software scalability. In 26Q1, this narrative broke. Software revenue declined 17% YoY, a stark contrast to the 41% growth seen in 25Q1. Management attributes this to declines in 'clinical operations and development revenue,' likely tied to the acquired Pro-ficiency assets, which were only partially offset by Discovery solutions.
Falling Renewal Rates
Stickiness is fading. The fee-based software renewal rate dropped to 88% (down from 95% in 25Q1 and 93% in 24Q1). The account-based renewal rate is even more alarming, sitting at 77% (TTM). This continuing deterioration suggests that the 'client consolidation' excuse may be masking underlying churn issues.
Services Backlog & Growth
Accelerating. Services revenue grew 16% YoY, a distinct improvement from the -3% decline in the prior quarter (25Q4). The backlog stands at $20.4M, providing coverage for roughly two quarters of service revenue. Growth was driven by commercialization offerings, helping offset the software weakness.
Profitability Compression
Decelerating. While Gross Margins improved, Adjusted EBITDA margin compressed to 19% from 24% a year ago. R&D expenses surged 61% YoY ($2.98M vs $1.85M) as the company invests in AI initiatives (GastroPlus X.2). This indicates the company is spending heavily to reignite growth, pressuring near-term profitability.
Mix Shift Away from Software
For the first time in recent history, Services revenue ($9.5M) exceeded Software revenue ($8.9M). Software mix dropped to 48% from 57% in the prior year. This shift structurally limits margin expansion potential, as Services typically carry lower gross margins than Software (though Q1 showed an anomaly with high Services GM).
AI Product Cycle
Management is banking on a new product vision to reverse trends, specifically the 'GastroPlus X.2' launch featuring AI-powered tools. An Investor Day is scheduled for Jan 21, 2026, to detail this vision. Success here is critical to arresting the software decline.
Other KPIs
Decelerating. Down from $0.17 in the prior year period. The decline reflects the negative leverage from falling revenue and increased R&D investment ($1.1M increase YoY).
Stable. Includes cash and short-term investments. Up slightly from $32.4M at FY25 year-end (Aug 31, 2025), indicating the company is not burning cash despite the net income pressure.
Accelerating. R&D spend increased 61% YoY and now represents 16% of total revenue (up from 10%). This confirms an aggressive investment phase into the new AI/Cloud platform.
Guidance
Stable/Low Growth. Implies 0% to 4% YoY growth. Given Q1 was -3%, the company needs to generate roughly +1% to +6% growth in the remaining three quarters to hit targets. This requires a rapid turnaround in the software business.
Accelerating vs Current Q. Q1 actual was 19%. Achieving the full-year guide requires a massive margin ramp in Q2-Q4, likely dependent on software revenue recovering to improve the mix.
Optimistic. Current Q1 mix was only 48%. To hit the bottom end of guidance (57%), software needs to significantly outperform services for the remainder of the year—a sharp reversal from the current trend where software is shrinking (-17%) and services is growing (+16%).
Flat to up slightly vs FY25 ($1.03). Reaffirmed guidance implies backend loaded profitability.
Key Questions
Bridge to Software Guidance
Q1 Software revenue fell 17% and mix was 48%. FY guidance calls for 57-62% software mix. What specific pipeline events or renewals give confidence in such a drastic reversal of trend for the remainder of the year?
Renewal Rate Stabilization
Fee-based renewal rates dropped to 88% and account-based to 77%. Is this solely due to the Pro-ficiency assets, and have you seen any churn in the core GastroPlus/ADMET user base?
Margin Ramp Credibility
Adjusted EBITDA margin was 19% in Q1. To hit the 26-30% full-year guide, margins need to average ~30% for the next three quarters. How is this achievable if R&D spend remains elevated at Q1 levels?